Raffles Medical posts 63.8% drop in H2 profit to S$30.3 million; looks to China, Japan growth
RAFFLES Medical Group posted a 63.8 per cent drop in net profit to S$30.3 million for the second half ended Dec 31, 2023, from S$83.7 million in the previous corresponding period.
The group attributed the weaker performance to the discontinuation of Covid-19-related activities in FY2023, it said on Monday (Feb 26).
The results translate to earnings per share (EPS) of 1.63 Singapore cents against EPS of 4.51 cents previously.
TRENDING NOW
UOB to sell asset management arm to Allianz Global Investors for S$555 million, sharpen wealth advisory focus
UOB CEO’s youngest child Grant Wee turns burnout into a wellness business
1 in 5 fresh graduates from autonomous universities still seeking employment: MOM
Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart